{"efta_number": "EFTA01939608", "page_count": 2, "url": "https://epstein-data.com/EFTA01939608", "pdf_url": "https://epstein-data.com/pdf/EFTA01939608.pdf", "pages": [{"efta_number": "EFTA01939608", "page_number": 0, "text_content": "Science Patron Jeffrey Epstein Collaborates with the Elton John AIDS Foundation to Combat HIV\nResistance\nThe well-known New York science philanthropist, Jeffrey Epstein, has put his support behind the celebrated Elton\nJohn AIDS Foundation (EJAF). The funding marks the collaborative backing for a cocktail approach to fighting\nthe HIV virus and critically for combatting resistance by targeting treatment on an individual basis, based on\ngenotype, blood type and many other factors.\nFor more than a decade now, scientists have agreed that a cocktail of inhibitors and other drugs have been critical\nto combatting the HIV virus. Viral resistance however has been a growing problem and what is emerging is the\ngrowing trend of targeting treatment on an individual basis to reduce the chance of resistant strains.\nIn 2000, Jeffrey Epstein, an established financier and science philanthropist, founded the Program for Evolutionary\nDynamics at Harvard University which, over the past three years, has collaborated with John Hopkins University to\ndevelop a database to map and predict the effect of drugs on the HIV virus. Like cancer cells, HIV can develop\nresistance to inhibitor drugs, even to drug combinations. Resistance is a growing problem for patients, who can\nstay on the same regimen of drugs for years, and the trial and error of clinical trials can be debilitating and\nlengthy. Using data collected from thousands of blood tests on more than 20 anti-HIV drugs, the Program for\nEvolutionary Dynamic's model calculates each drug's ability to suppress viral replication and avoid resistant HIV\nstrains. The model factors in different drug combinations and dosages, but also blood type, viral genotype, viral\nload, HIV stage, treatment history, age, sex and a host of other variables to arrive at the most precisely engineered\npredictor of results for future patients.\nFounded in 1993 by Sir Elton John, the Elton John AIDS Foundation (EJAF) is one of the world's leading\nnonprofits in the field of HIV/AIDS. Since its inception, EJAF has raised more than $300 million to fund worthy\nprojects across the globe. The EJAF also supports direct services for persons living with HIV/AIDS, including\nmedical and mental health treatment, testing and counseling services, case management and social service\ncoordination, legal aid, and professional training.\nOver the last decade, the EJAF has awarded funding for the outstanding HIV Drug Resistance Database at\nStanford Univeristy's Clinical Virology Laboratory in California. The database provides the largest publicly\navailable resource for HIV drug resistance surveillance, interpreting HIV drug resistance tests, and developing new\nantiretroviral drugs. The database has more than 90,000 HIV sequences from approximately 80,000 distinct virus\nisolations obtained from nearly 40,000 individuals. When presented with an HIV sequence, the genotypic\nresistance interpretation algorithm takes into consideration hundreds of factors including: correlations between\ngenotypic data with the treatments of persons from whom sequenced HIV-1 isolates have been obtained (genotype-\ntreatment); (2) Correlations between genotype and in vitro drug susceptibility (genotype-phenotype); and (3)\nCorrelations between genotype and the clinical response to a new treatment regimen (genotype-outcome) to render\nan interpretation.\n\"The next great advance in HIV treatment will be the ability to foresee viral resistance and to avert it before it\ndevelops,\" Jeffrey Epstein remarked.\nEFTA_R1_00397326\nEFTA01939608\n", "char_count": 3542}, {"efta_number": "EFTA01939608", "page_number": 1, "text_content": "Since its discovery, AIDS has caused an estimated 36 million deaths (as of 2012). Today, approximately\n35.3 million people live with HIV globally. AIDS is still considered a pandemic, a disease outbreak that exists over\na large area and is actively spreading.\nJeffrey Epstein is the founder of the Program for Evolutionary Dynamics at Harvard University and a former\nmember of the Mind, Brain and Behavior Committee at Harvard. He is one of the largest sponsors of individual\nscientists around the world including many eminent Nobel Laureates. He is a former board member of Rockefeller\nUniversity, the Trilateral Commission and the Council for Foreign Relations. His foundation, the Jeffrey Epstein\nVI Foundation was established in 2000 to support cutting edge science research around the world.\nEFTA_R1_00397327\nEFTA01939609\n", "char_count": 827}]}